Beta Drugs H2FY22 consolidated PAT jumps to Rs. 13.07 crores

Beta Drugs Ltd has reported consolidated financial results for the period ended March 31, 2022.

Financial Results (H2 FY21-22) - YoY Comparison

The company has reported net sales of Rs.96.04 crores during the 6 months period ended March 31, 2022 as compared to Rs.64.98 crores during the 6 months period ended March 31, 2021.

The company has posted net profit of Rs.13.07 crores for the 6 months period ended March 31, 2022 as against Rs.6.54 crores for the 6 months period ended March 31, 2021.

The company has reported EPS of Rs.13.60 for the 6 months period ended March 31, 2022 as compared to Rs.6.81 for the 6 months period ended March 31, 2021.

Financials	H1 FY21-22	H1 FY20-21	% Change
Total Income	₹ 96.04 crs	₹ 64.98 crs	47.8%
Net Profit	₹ 13.07 crs	₹ 6.54 crs	99.85%
EPS	₹ 13.60	₹ 6.81	99.71%

Financial Results (Year ended FY 2021-22) - YoY Comparison

The company has reported net sales of Rs.184.59 crores for the year ended March 31, 2022 as compared to Rs.116.61 crores for the year ended March 31, 2021.

The company has posted net profit of Rs.24.82 crores for the year ended March 31, 2022 as against Rs.11.72 crores for the year ended March 31, 2021.

The company has reported EPS of Rs.25.82 for the year ended March 31, 2022 as compared to Rs.12.20 for the year ended March 31, 2021.

Financials	FY2020-21	FY2019-20	% Change
Total Income	₹ 184.59 crs	₹ 116.61 crs	58.3%
Net Profit	₹ 24.82 crs	₹ 11.72 crs	111.77%
EPS	₹ 25.82	₹12.20	111.64%

Shares of Beta Drugs Ltd was last trading in NSE at Rs. 710 as compared to the previous close of Rs. 720.80. The total number of shares traded during the day was 14,000 and the deliverable quantity was 10,600.

The stock hit an intraday high of Rs. 729 and intraday low of 688.

Source : Equity Bulls

Keywords

BetaDrugs H2FY22 FY2022 ResultUpdate